"Receptors, Cannabinoid" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A class of G-protein-coupled receptors that are specific for CANNABINOIDS such as those derived from CANNABIS. They also bind a structurally distinct class of endogenous factors referred to as ENDOCANNABINOIDS. The receptor class may play a role in modulating the release of signaling molecules such as NEUROTRANSMITTERS and CYTOKINES.
| Descriptor ID |
D043882
|
| MeSH Number(s) |
D12.776.543.750.695.125
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Receptors, Cannabinoid".
Below are MeSH descriptors whose meaning is more specific than "Receptors, Cannabinoid".
This graph shows the total number of publications written about "Receptors, Cannabinoid" by people in this website by year, and whether "Receptors, Cannabinoid" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2016 | 0 | 1 | 1 |
| 2018 | 2 | 2 | 4 |
To return to the timeline, click here.
Below are the most recent publications written about "Receptors, Cannabinoid" by people in Profiles.
-
Cannabis sativa L. as a Natural Drug Meeting the Criteria of a Multitarget Approach to Treatment. Int J Mol Sci. 2021 Jan 14; 22(2).
-
Proteomics and Lipidomics in the Elucidation of Endocannabinoid Signaling in Healthy and Schizophrenia Brains. Proteomics. 2018 09; 18(18):e1700270.
-
Cannabinoids for the treatment of rheumatic diseases - where do we stand? Nat Rev Rheumatol. 2018 08; 14(8):488-498.
-
Anandamide and endocannabinoid system: an attractive therapeutic approach for cardiovascular disease. Ther Adv Cardiovasc Dis. 2018 Jul; 12(7):177-190.
-
Loss of toll-like receptor 3 aggravates hepatic inflammation but ameliorates steatosis in mice. Biochem Biophys Res Commun. 2018 03 18; 497(4):957-962.
-
Cannabinoids: Possible agents for treatment of psoriasis via suppression of angiogenesis and inflammation. Med Hypotheses. 2017 Feb; 99:15-18.